UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cardiac safety of trastuzumab in combination with epirubicin and cyclophosphamide in women with metastatic breast cancer: results of a phase I trial

European journal of cancer (1990), 2004-05, Vol.40 (7), p.988-997

2004

Volltextzugriff (PDF)

Früherkennung von Ovarialkarzinomen

Oncology research and treatment, 1995-03, Vol.18 (3), p.46-50

Meerpohl, H.G.

1995

Volltextzugriff (PDF)

Chemotherapie fortgeschrittener epithelialer Ovarialkarzinome

Oncology research and treatment, 1984-02, Vol.7 (2), p.22-34

Meerpohl, H.G.

1984

Volltextzugriff (PDF)

Extended phase II study of paclitaxel as a 3-h infusion in patients with ovarian cancer previously treated with platinum

European journal of cancer (1990), 1997-03, Vol.33 (3), p.379-384

1997

Volltextzugriff (PDF)

Course, patterns, and risk-factors for chemotherapy-induced emesis in cisplatin-pretreated patients: a study with ondansetron

European journal of cancer (1990), 1992, Vol.28 (2), p.450-457

1992

Volltextzugriff (PDF)

Clinical phase I study with one-hour paclitaxel infusion

Annals of oncology, 1998-05, Vol.9 (5), p.569-572

1998

Volltextzugriff (PDF)

Randomized Study Comparing Carboplatin/Cyclophosphamide and Cisplatin/Cyclophosphamide as First-Line Treatment in Patients with Stage III/IV Epithelial Ovarian Cancer and Small Volume Disease

Gynecologic oncology, 1997-07, Vol.66 (1), p.75-84

1997

Volltextzugriff (PDF)

Positron emission tomography helps to diagnose tumor emboli and residual disease in choriocarcinoma

Annals of oncology, 1996-04, Vol.7 (4), p.416-418

1996

Volltextzugriff (PDF)

Cardiac safety of trastuzumab in combination with epirubicin and cyclophosphamide in women with metastatic breast cancer

European journal of cancer (1990), 2004-05, Vol.40 (7), p.988-997

2004

Volltextzugriff (PDF)

Pathophysiology, severity, pattern, and risk factors for carboplatin-induced emesis

Oncology, 1996-01, Vol.53 Suppl 1 (1), p.46-50

1996

Volltextzugriff (PDF)

Paclitaxel-Induced “Recall” Soft Tissue Ulcerations Occurring at the Site of Previous Subcutaneous Administration of Paclitaxel in Low Doses

Gynecologic oncology, 1996-01, Vol.60 (1), p.94-96

1996

Volltextzugriff (PDF)

Prospective investigation of the significance of cardiac markers, NT-pro Brain Natriuretic Peptide (NT-proBNP) and Troponin T (TnT), in the Hercules study of epirubicin/cyclophosphamide with or without trastuzumab (Herceptin®)

European journal of cancer supplements, 2004-03, Vol.2 (3), p.143-143

2004

Volltextzugriff (PDF)

Clinical and pharmacokinetic phase I study with taxol® given as short 1-hour intravenous infusion

European journal of cancer (1990), 1997-09, Vol.33, p.S251-S251

1997

Volltextzugriff (PDF)

Combined radio‐chemotherapy in advanced cervical cancer: a phase‐II trial with weekly applied carboplatin, 5‐fluorouracil and folinic acid

International journal of gynecological cancer, 1996-01, Vol.6 (1), p.20-26

1996

Volltextzugriff (PDF)

Role of prostaglandins on the regulation of macrophage proliferation and cytotoxic functions

Prostaglandins, 1986-05, Vol.31 (5), p.961-972

1986

Volltextzugriff (PDF)

Mitoxantrone Therapy of Advanced Adenocarcinoma of the Endometrium

Oncology research and treatment, 1989-02, Vol.12 (2), p.102-103

1989

Volltextzugriff (PDF)

Implementation of Doppler Ultrasound for Therapy Control of Breast Malignancies Treated with Chemotherapy

Oncology research and treatment, 1993, Vol.16 (3), p.183-188

1993

Volltextzugriff (PDF)

Kontrolle des Ansprechens von Ovarialkarzinomen auf die zytostatische Therapie und Stellenwert der Second-look-Operation

Oncology research and treatment, 1985-06, Vol.8 (6), p.356-363

1985

Volltextzugriff (PDF)

Formation of prostaglandins by ovarian carcinomas

Prostaglandins, 1985-05, Vol.29 (5), p.665-672

1985

Volltextzugriff (PDF)

Therapierefraktäre Emesis unter Cisplatin

Oncology research and treatment, 1990-05, Vol.13 (5), p.364-368

1990

Volltextzugriff (PDF)

Chemotherapy for stage III-IV ovarian cancer: the CAP-regimen in previously untreated patients

Oncology research and treatment, 1982-01, Vol.5 (5), p.238-241

1982

Volltextzugriff (PDF)

354 EGF receptors and ornithine decarboxylase: Prognostic value in ovarian carcinomas

Journal of steroid biochemistry, 1983, Vol.19, p.118-118

1983

Volltextzugriff (PDF)

1 – 22 von 22

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(14)

Publikationsform

Artikel
(22)

Sprache

Englisch
(22)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(12)
Science & Technology
(12)
Biological And Medical Sciences
(10)
Medical Sciences
(10)
Oncology
(10)
Female
(9)
Humans
(8)
Adult
(6)
Middle Aged
(6)
Pharmacology. Drug Treatments
(6)
Aged
(4)
Male
(4)
Tumors
(4)
Chemotherapy
(3)
Drug Toxicity And Drugs Side Effects Treatment
(3)
Gynecology. Andrology. Obstetrics
(3)
Obstetrics & Gynecology
(3)
Animals
(2)
Antiemetics - Therapeutic Use
(2)
Antineoplastic Agents
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cardiac safety of trastuzumab in combination with epirubicin and cyclophosphamide in women with metastatic breast cancer: results of a phase I trial

Früherkennung von Ovarialkarzinomen

Chemotherapie fortgeschrittener epithelialer Ovarialkarzinome

Extended phase II study of paclitaxel as a 3-h infusion in patients with ovarian cancer previously treated with platinum

Course, patterns, and risk-factors for chemotherapy-induced emesis in cisplatin-pretreated patients: a study with ondansetron

Clinical phase I study with one-hour paclitaxel infusion

Randomized Study Comparing Carboplatin/Cyclophosphamide and Cisplatin/Cyclophosphamide as First-Line Treatment in Patients with Stage III/IV Epithelial Ovarian Cancer and Small Volume Disease

Positron emission tomography helps to diagnose tumor emboli and residual disease in choriocarcinoma

Cardiac safety of trastuzumab in combination with epirubicin and cyclophosphamide in women with metastatic breast cancer

Pathophysiology, severity, pattern, and risk factors for carboplatin-induced emesis

Paclitaxel-Induced “Recall” Soft Tissue Ulcerations Occurring at the Site of Previous Subcutaneous Administration of Paclitaxel in Low Doses

Prospective investigation of the significance of cardiac markers, NT-pro Brain Natriuretic Peptide (NT-proBNP) and Troponin T (TnT), in the Hercules study of epirubicin/cyclophosphamide with or without trastuzumab (Herceptin®)

Clinical and pharmacokinetic phase I study with taxol® given as short 1-hour intravenous infusion

Combined radio‐chemotherapy in advanced cervical cancer: a phase‐II trial with weekly applied carboplatin, 5‐fluorouracil and folinic acid

Role of prostaglandins on the regulation of macrophage proliferation and cytotoxic functions

Mitoxantrone Therapy of Advanced Adenocarcinoma of the Endometrium

Implementation of Doppler Ultrasound for Therapy Control of Breast Malignancies Treated with Chemotherapy

Kontrolle des Ansprechens von Ovarialkarzinomen auf die zytostatische Therapie und Stellenwert der Second-look-Operation

Formation of prostaglandins by ovarian carcinomas

Therapierefraktäre Emesis unter Cisplatin

Chemotherapy for stage III-IV ovarian cancer: the CAP-regimen in previously untreated patients

354 EGF receptors and ornithine decarboxylase: Prognostic value in ovarian carcinomas

Suchergebnisse filtern